Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
SEMINARS IN LIVER DISEASE
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2023-11-07
DOI
10.1055/s-0043-1776127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition
- (2023) Shengwei Tao et al. Frontiers in Immunology
- Transforming Cold Tumors into Hot Ones with a Metal–Organic Framework-Based Biomimetic Nanosystem for Enhanced Immunotherapy
- (2023) Manman Xu et al. ACS Applied Materials & Interfaces
- PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma
- (2023) Petros Fessas et al. Future Oncology
- Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
- (2023) Matthias Pinter et al. Lancet Gastroenterology & Hepatology
- Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
- (2022) Uasim Harkus et al. SEMINARS IN CANCER BIOLOGY
- Myeloid‑derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
- (2022) Takahiro Tomiyama et al. Oncology Letters
- Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization
- (2022) Hans Urban et al. Frontiers in Immunology
- RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
- (2022) Xiao Wang et al. Frontiers in Oncology
- Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?
- (2022) Claudia Angela Maria Fulgenzi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
- (2022) Yuting Lu et al. Journal of Hematology & Oncology
- PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma
- (2022) Chuan-Yuan Wei et al. JOURNAL OF HEPATOLOGY
- Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma
- (2022) Rongfeng Shi et al. Aging-US
- Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities
- (2022) Qingqing Xie et al. Frontiers in Oncology
- Immune checkpoint inhibitor resistance in hepatocellular carcinoma
- (2022) Zhijie Wang et al. CANCER LETTERS
- Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis
- (2021) Ilario Giovanni Rapposelli et al. Cancers
- The EGFR‐P38 MAPK axis up‐regulates PD‐L1 through miR‐675‐5p and down‐regulates HLA‐ABC via hexokinase‐2 in hepatocellular carcinoma cells
- (2021) Zongcai Liu et al. Cancer Communications
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Investigation on potential biomarkers of hyperprogressive disease (HPD) triggered by immune checkpoint inhibitors (ICIs)
- (2021) J. Liu et al. Clinical & Translational Oncology
- Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma
- (2021) Won‐Mook Choi et al. LIVER INTERNATIONAL
- Advances in immunotherapy for hepatocellular carcinoma
- (2021) Bruno Sangro et al. Nature Reviews Gastroenterology & Hepatology
- A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
- (2021) Weiqin Yang et al. Science Translational Medicine
- Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma
- (2021) Qijun Li et al. Frontiers in Immunology
- Immune Aging and Immunotherapy in Cancer
- (2021) Melanie Kaiser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
- (2021) Kyoko Oura et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune PET Imaging
- (2021) Osigbemhe Iyalomhe et al. RADIOLOGIC CLINICS OF NORTH AMERICA
- Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
- (2021) Yangtao Xu et al. Frontiers in Cell and Developmental Biology
- Hyperprogression under immunotherapy: a new form of immunotherapy response?—a narrative literature review
- (2021) Miaozhen Lin et al. Translational Lung Cancer Research
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
- (2021) Golnaz Morad et al. CELL
- Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
- (2021) Kazuki Maesaka et al. HEPATOLOGY RESEARCH
- The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
- (2021) Xin Hu et al. International Journal of Biological Sciences
- Nanomaterials targeting tumor associated macrophages for cancer immunotherapy
- (2021) Caiyan Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
- (2021) Jia-Cheng Lu et al. Journal of Hematology & Oncology
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Comparative assessment of standard and immune response criteria for evaluation of response to PD-1 monotherapy in unresectable HCC
- (2021) Sara Lewis et al. Abdominal Radiology
- Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?
- (2021) Dong Ho Lee et al. Frontiers in Medicine
- Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
- (2021) Mahshid Deldar Abad Paskeh et al. Journal of Hepatocellular Carcinoma
- A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma
- (2021) Gouri Pandya et al. SEMINARS IN CANCER BIOLOGY
- Programmed Cell Death Protein-1 (PD-1)-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma in Real World
- (2020) Hanzhi Cui et al. OncoTargets and Therapy
- Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
- (2020) Lin Shui et al. Frontiers in Immunology
- Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications
- (2020) Pierre Decazes et al. Cancers
- Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
- (2020) Maxime Frelaut et al. BIODRUGS
- Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non–small Cell Lung Cancer
- (2020) Giuseppe Lo Russo et al. Current Oncology Reports
- Towards a more precise therapy in cancer: Exploring epigenetic complexity
- (2020) Fernando P. Cossío et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The role of gut microbiota in cancer treatment: friend or foe?
- (2020) Wing Yin Cheng et al. GUT
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of anti-PD-1 for hepatocellular carcinoma – Authors' reply
- (2020) Shukui Qin et al. LANCET ONCOLOGY
- 998P The biomarkers associated with hyperprogression (HP) to immune checkpoint inhibitors (ICIs) in Chinese hepatocellular carcinoma (HCC) patients
- (2020) C. Wei et al. ANNALS OF ONCOLOGY
- Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma
- (2020) Laia Bassaganyas et al. CLINICAL CANCER RESEARCH
- Hyperprogression in hepatocellular carcinoma: Illusion or reality?
- (2020) Stephen L. Chan JOURNAL OF HEPATOLOGY
- Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
- (2020) Chang Gon Kim et al. JOURNAL OF HEPATOLOGY
- High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
- (2020) Beng Yang et al. ONCOGENE
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells
- (2020) Dong Li et al. ONCOLOGY RESEARCH
- Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma
- (2020) Stephan Spahn et al. Cancers
- Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice
- (2020) Jordi Rimola et al. EUROPEAN JOURNAL OF RADIOLOGY
- Novel patterns of response under immunotherapy
- (2019) E Borcoman et al. ANNALS OF ONCOLOGY
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
- (2019) Takeshi Tanoue et al. NATURE
- Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case series
- (2019) Daniel Jiahao Wong et al. Immunotherapy
- Endoplasmic Reticulum Stress Promotes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate PD-L1 Expression in Macrophages
- (2019) Jiatao Liu et al. HEPATOLOGY
- Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
- (2019) Bernhard Scheiner et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience
- (2019) Luca Rinaldi et al. DIGESTIVE DISEASES AND SCIENCES
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
- (2019) Yu Zheng et al. Molecular Cancer
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Hyperprogression during immunotherapy: do we really want to know?
- (2019) S Champiat et al. ANNALS OF ONCOLOGY
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study
- (2019) Xubiao Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma
- (2019) Ling Deng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
- (2019) Yi Zheng et al. Journal for ImmunoTherapy of Cancer
- Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer
- (2019) Ilaria Alborelli et al. JOURNAL OF PATHOLOGY
- Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
- (2019) Bettina Langhans et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma
- (2019) Shaw M. Akula et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
- (2019) Ssu-Chuan Lai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FDG PET Findings of Hyperprogression During Immunotherapy in a Patient With Hepatocellular Carcinoma
- (2019) Jingnan Wang et al. CLINICAL NUCLEAR MEDICINE
- Hyperprogression as a Distinct Outcome after Immunotherapy
- (2018) J. Fuentes-Antrás et al. CANCER TREATMENT REVIEWS
- Cancer epigenetics: Moving forward
- (2018) Angela Nebbioso et al. PLoS Genetics
- Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
- (2018) Rikke B. Holmgaard et al. Journal for ImmunoTherapy of Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients
- (2018) Jung Youn Kim et al. NEURO-ONCOLOGY
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
- (2018) Diana Llopiz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies
- (2018) James J Harding et al. CLINICAL CANCER RESEARCH
- Evaluation of Post-Stereotactic Body Radiation Therapy Response Assessment for Hepatocellular Carcinoma: An Appraisal of RECIST, m-RECIST and WHO Criteria
- (2018) D.J. Godfrey et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
- (2018) Wenliang Tan et al. EBioMedicine
- Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
- (2018) Giuseppe Lo Russo et al. CLINICAL CANCER RESEARCH
- Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells
- (2017) Bo Lin et al. INTERNATIONAL JOURNAL OF CANCER
- The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion
- (2017) Marija Mojic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transient Increases of Serum AFP and PIVKA-II Levels After Proton Therapy Do Not Necessarily Indicate Progression of Hepatocellular Carcinoma
- (2017) M. Yoshida et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis
- (2017) C. Floridi et al. MEDICAL ONCOLOGY
- Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma
- (2017) Jianhua Liu et al. ONCOLOGY REPORTS
- Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
- (2017) Scott Gettinger et al. Cancer Discovery
- P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer
- (2017) Dongfang Tang et al. Oncotarget
- Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
- (2017) Lejia Sun et al. Oncotarget
- Lenvatinib mesilate (LEN) enhanced antitumor activity of a PD-1 blockade agent by potentiating Th1 immune response
- (2016) Y. Kato et al. ANNALS OF ONCOLOGY
- Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
- (2016) Andrea Kristina Horst et al. Cellular & Molecular Immunology
- Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
- (2016) Stéphane Champiat et al. CLINICAL CANCER RESEARCH
- Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
- (2016) Simone Jueliger et al. Epigenetics
- Wnt signaling networks in autism spectrum disorder and intellectual disability
- (2016) Vickie Kwan et al. Journal of Neurodevelopmental Disorders
- Report of two cases of pseudoprogression in patients with non–small cell lung cancer treated with nivolumab—including histological analysis of one case after tumor regression
- (2016) Junko Tanizaki et al. LUNG CANCER
- TGFβ signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells
- (2016) Nathan Ungerleider et al. MOLECULAR CARCINOGENESIS
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
- (2016) Andrea Casadei Gardini et al. Oncotarget
- Prognostic role of Child-Pugh score 5 and 6 in hepatocellular carcinoma patients who underwent curative hepatic resection
- (2015) Chisato Okajima et al. AMERICAN JOURNAL OF SURGERY
- Improving cancer immunotherapy with DNA methyltransferase inhibitors
- (2015) Mohammad H. Saleh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Histone Deacetylase HDAC8 Promotes Insulin Resistance and -Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
- (2015) Y. Tian et al. CANCER RESEARCH
- Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
- (2015) Xavier Adhoute et al. JOURNAL OF HEPATOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells
- (2015) Xin Wan et al. Oncotarget
- Controlling T cell senescence in the tumor microenvironment for tumor immunotherapy
- (2015) Jian Ye et al. OncoImmunology
- A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6
- (2015) Hung-Hsu Hung et al. MEDICINE
- Biochemical Signaling of PD-1 on T Cells and Its Functional Implications
- (2014) Vassiliki A. Boussiotis et al. CANCER JOURNAL
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements
- (2013) M. Nishino et al. CLINICAL CANCER RESEARCH
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
- (2013) Wolfgang Sieghart et al. HEPATOLOGY
- Understanding immunosenescence to improve responses to vaccines
- (2013) Jörg J Goronzy et al. NATURE IMMUNOLOGY
- The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells
- (2013) Shiguo Zhu et al. PHARMACEUTICAL RESEARCH
- Human T Cell Aging and the Impact of Persistent Viral Infections
- (2013) T. Fülöp et al. Frontiers in Immunology
- The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome
- (2012) B. Costantini et al. HAEMATOLOGICA
- PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer
- (2012) John Dulos et al. JOURNAL OF IMMUNOTHERAPY
- Innate immunosenescence: Effect of aging on cells and receptors of the innate immune system in humans
- (2012) Rafael Solana et al. SEMINARS IN IMMUNOLOGY
- Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know
- (2010) Mizuki Nishino et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Flare-up: An often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors
- (2009) Pascal Wolter et al. ACTA ONCOLOGICA
- Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
- (2009) Anna Maria Di Giacomo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
- (2009) I. Kryczek et al. CANCER RESEARCH
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats
- (2008) Yong Chen et al. LIVER TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started